{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T07:08:54Z","timestamp":1778742534387,"version":"3.51.4"},"reference-count":61,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,3,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Tuberculosis (TB) is a communicable disease that poses a threat to force health protection to the U.S. military. The rate of TB disease in the military is low; however, there are unique challenges for its control in this setting. As a low-risk population, TB testing in the U.S. military can be scaled back from the universal testing approach used previously. Reactivation of latent TB infection (LTBI) present at accession into service is the most important factor leading to TB disease; therefore, its diagnosis and treatment among recruits should be given a high priority. Deployment and overseas military service is an uncommon but important source of TB infection, and rigorous surveillance should be ensured. Case management of TB disease and LTBI can be improved by the use of cohort reviews at the service and installation levels and case finding and delays in the diagnosis of TB disease can be improved by education of providers, as well as increased use of molecular diagnostic tests. Program outcomes can be improved by making LTBI treatment compulsory, offering shorter treatment regimens, and increasing accountability through oversight and evaluation. The diagnosis of LTBI can be improved by implementing targeted testing in all settings and reducing confirmatory interferon-gamma release assay testing.<\/jats:p>","DOI":"10.7205\/milmed-d-14-00433","type":"journal-article","created":{"date-parts":[[2015,2,27]],"date-time":"2015-02-27T10:44:22Z","timestamp":1425033862000},"page":"276-284","source":"Crossref","is-referenced-by-count":9,"title":["Tuberculosis as a Force Health Protection Threat to the United States Military"],"prefix":"10.1093","volume":"180","author":[{"given":"Jose L.","family":"Sanchez","sequence":"first","affiliation":[{"name":"*Armed Forces Health Surveillance Center (AFHSC) and Cherokee Nation Technology Solutions, Inc., 11800 Tech Road, Suite 220, Silver Spring, MD 20904."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joyce L.","family":"Sanchez","sequence":"additional","affiliation":[{"name":"\u2020Mayo Clinic, Division of General Internal Medicine, 200 First Street SW, Rochester, MN 55905."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Cooper","sequence":"additional","affiliation":[{"name":"\u2021Armed Forces Health Surveillance Center (AFHSC), 11800 Tech Road, Suite 220, Silver Spring, MD 20904."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle J.","family":"Hiser","sequence":"additional","affiliation":[{"name":"\u2021Armed Forces Health Surveillance Center (AFHSC), 11800 Tech Road, Suite 220, Silver Spring, MD 20904."},{"name":"\u00a7Oak Ridge Institute for Science and Education (ORISE), Postgraduate Research Participation Program, U.S. Army Public Health Command (USAPHC), 5158 Blackhawk Road, Aberdeen Proving Ground, MD 21010."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James D.","family":"Mancuso","sequence":"additional","affiliation":[{"name":"\u2016Department of Preventive Medicine and Biometrics, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD 20814."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2015,3,1]]},"reference":[{"issue":"5","key":"2026051402253304600_bib1","first-page":"4","article-title":"Tuberculosis trends in the U.S. Armed Forces, active component, 1998\u20132012","volume":"20","author":"Mancuso","year":"2013","journal-title":"MSMR"},{"issue":"1","key":"2026051402253304600_bib2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/00039896.1968.10665008","article-title":"Tuberculosis control in the United States Navy: 1875\u20131966","volume":"16","author":"Hanzel","year":"1968","journal-title":"Arch Environ Health"},{"key":"2026051402253304600_bib3","first-page":"147","article-title":"Tuberculosis epidemiology in the World War","volume":"37","author":"Bushnell","year":"1921","journal-title":"Trans Am Climatol Assoc"},{"issue":"1","key":"2026051402253304600_bib4","first-page":"28","article-title":"The tuberculosis experience of the United States Army in World War II","volume":"55","author":"Long","year":"1947","journal-title":"Am Rev Tuberc"},{"key":"2026051402253304600_bib5","first-page":"133","article-title":"Tuberculosis","volume-title":"Recent Advances in Medicine and Surgery based on Professional Medical Experiences in Japan and Korea 1950\u20131953","author":"Leedham","year":"1954"},{"issue":"4","key":"2026051402253304600_bib6","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1001\/jama.1969.03150170023004","article-title":"Public health problems relating to the Vietnam returnee","volume":"207","author":"Greenberg","year":"1969","journal-title":"JAMA"},{"issue":"5","key":"2026051402253304600_bib7","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1093\/milmed\/166.5.452","article-title":"Active tuberculosis among U.S. Army personnel, 1980 to 1996","volume":"166","author":"Camarca","year":"2001","journal-title":"Mil Med"},{"issue":"2","key":"2026051402253304600_bib8","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.amepre.2010.03.017","article-title":"Active tuberculosis and recent overseas deployment in the U.S. military","volume":"39","author":"Mancuso","year":"2010","journal-title":"Am J Prev Med"},{"issue":"11","key":"2026051402253304600_bib9","first-page":"229","article-title":"Trends in tuberculosis\u2014United States, 2013","volume":"63","author":"Alami","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2026051402253304600_bib10","volume-title":"Medical Standards for Appointment, Enlistment, or Induction in the Military Services","author":"Department of Defense Instruction 6130.03","year":"2010"},{"issue":"3","key":"2026051402253304600_bib11","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1164\/rccm.200701-057OC","article-title":"Prevalence of tuberculosis infection in the United States population: the national health and nutrition examination survey, 1999\u20132000","volume":"177","author":"Bennett","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"2026051402253304600_bib12","unstructured":"Batalova\n              \u00a0J\n          \n          \u00a0Immigrants in the U.S. Armed Forces. Migration Information Source, May15, 2008. Available at http:\/\/www.migrationpolicy.org\/article\/immigrants-us-armed-forces; accessed October 23, 2014."},{"issue":"RR-6","key":"2026051402253304600_bib13","first-page":"1","article-title":"Targeted tuberculin testing and treatment of latent tuberculosis infection. American Thoracic Society","volume":"49","author":"Centers for Disease Control and Prevention (CDC)","year":"2000","journal-title":"MMWR Recomm Rep"},{"key":"2026051402253304600_bib14","volume-title":"Core Curriculum on Tuberculosis","author":"CDC","year":"2013","edition":"Ed 6"},{"issue":"3","key":"2026051402253304600_bib15","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/cid\/cir321","article-title":"Impact of targeted testing for latent tuberculosis infection using commercially available diagnostics","volume":"53","author":"Mancuso","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"2","key":"2026051402253304600_bib16","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/milmed\/166.2.116","article-title":"Tuberculosis infection after humanitarian assistance, Guantanamo Bay, 1995","volume":"166","author":"Kortepeter","year":"2001","journal-title":"Mil Med"},{"key":"2026051402253304600_bib17","first-page":"329","article-title":"Tuberculosis in the Army, Chapter XI","volume-title":"Internal Medicine in World War II","author":"Long","year":"1955"},{"key":"2026051402253304600_bib18","volume-title":"Assistant Secretary of Defense for Health Affairs Memorandum, Guideline for Tuberculosis Screening and Testing","author":"Department of Defense","year":"2012"},{"key":"2026051402253304600_bib19","volume-title":"Global Tuberculosis Report 2014","author":"World Health Organization (WHO)","year":"2014"},{"issue":"20","key":"2026051402253304600_bib20","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1056\/NEJMsa031667","article-title":"Priorities for the treatment of latent tuberculosis infection in the United States","volume":"350","author":"Horsburgh","year":"2004","journal-title":"N Engl J Med"},{"issue":"5","key":"2026051402253304600_bib21","first-page":"9","article-title":"Using the tuberculosis cohort review to evaluate and improve the U.S. Army's tuberculosis control program","volume":"20","author":"Aaron","year":"2013","journal-title":"MSMR"},{"issue":"3","key":"2026051402253304600_bib22","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1001\/jama.1968.03140030007002","article-title":"Epidemiology of tuberculosis aboard a ship","volume":"203","author":"Hardy","year":"1968","journal-title":"JAMA"},{"issue":"1","key":"2026051402253304600_bib23","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1080\/00039896.1968.10665007","article-title":"The Byrd study. In-depth analysis of a micro-outbreak of tuberculosis in a closed environment","volume":"16","author":"Houk","year":"1968","journal-title":"Arch Environ Health"},{"issue":"6","key":"2026051402253304600_bib24","doi-asserted-by":"crossref","first-page":"588","DOI":"10.7205\/MILMED.173.6.588","article-title":"Investigation of Mycobacterium tuberculosis transmission aboard the U.S.S. Ronald Reagan, 2006","volume":"173","author":"Buff","year":"2008","journal-title":"Mil Med"},{"issue":"7","key":"2026051402253304600_bib25","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/milmed\/168.7.523","article-title":"Tuberculosis outbreak investigation of a U.S. Navy amphibious ship crew and the Marine expeditionary unit aboard, 1998","volume":"168","author":"Lamar","year":"2003","journal-title":"Mil Med"},{"issue":"11","key":"2026051402253304600_bib26","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJMoa0907847","article-title":"Rapid molecular detection of tuberculosis and rifampin resistance","volume":"363","author":"Boehme","year":"2010","journal-title":"N Engl J Med"},{"issue":"9776","key":"2026051402253304600_bib27","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/S0140-6736(11)60438-8","article-title":"Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB\/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study","volume":"377","author":"Boehme","year":"2011","journal-title":"Lancet"},{"issue":"1","key":"2026051402253304600_bib28","first-page":"7","article-title":"Updated guidelines for the use of nucleic acid amplification tests in the diagnosis of tuberculosis","volume":"58","author":"CDC","year":"2009","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"RR-5","key":"2026051402253304600_bib29","first-page":"1","article-title":"Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection\u2014United States, 2010","volume":"59","author":"Mazurek","year":"2010","journal-title":"MMWR Recomm Rep"},{"issue":"4 Pt 1","key":"2026051402253304600_bib30","first-page":"1376","article-title":"Diagnostic Standards and Classification of Tuberculosis in Adults and Children. This official statement of the American Thoracic Society and the Centers for Disease Control and Prevention was adopted by the ATS Board of Directors, July 1999. This statement was endorsed by the Council of the Infectious Disease Society of America, September 1999","volume":"161","author":"CDC","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"issue":"RR-17","key":"2026051402253304600_bib31","first-page":"1","article-title":"Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005","volume":"54","author":"Jensen","year":"2005","journal-title":"MMWR Recomm Rep"},{"key":"2026051402253304600_bib32","volume-title":"Mantoux Tuberculin Skin Testing Products","author":"CDC","year":"2012"},{"issue":"1","key":"2026051402253304600_bib33","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1164\/ajrccm.159.1.9801120","article-title":"Interpretation of repeated tuberculin tests. Boosting, conversion, and reversion","volume":"159","author":"Menzies","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"2026051402253304600_bib34","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1164\/rccm.200802-223OC","article-title":"Pseudoepidemics of tuberculin skin test conversions in the U.S. Army after recent deployments","volume":"177","author":"Mancuso","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"2026051402253304600_bib35","volume-title":"Assistant Secretary of Defense for Health Affairs, HA Policy 08-012, Policy for the Use of Tubersol as the Preferred Brand of Tuberculin","author":"Department of Defense","year":"2008"},{"key":"2026051402253304600_bib36","volume-title":"United States Army Medical Command, MEDCOM Regulation 40-64, The Tuberculosis Surveillance and Control Program","author":"Department of the Army","year":"2013"},{"issue":"4","key":"2026051402253304600_bib37","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1164\/rccm.201107-1244OC","article-title":"Discordance among commercially available diagnostics for latent tuberculosis infection","volume":"185","author":"Mancuso","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"2026051402253304600_bib38","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1164\/rccm.201211-2033ED","article-title":"The elusive \u201cgold\u201d standard for detecting Mycobacterium tuberculosis infection","volume":"187","author":"Mancuso","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"2026051402253304600_bib39","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1164\/rccm.201302-0365OC","article-title":"Interferon-gamma release assays and tuberculin skin testing for diagnosis of latent tuberculosis infection in healthcare workers in the United States","volume":"189","author":"Dorman","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"2026051402253304600_bib40","doi-asserted-by":"crossref","first-page":"865","DOI":"10.7205\/MILMED-D-11-00099","article-title":"Deployment-related testing and treatment for latent tuberculosis infection, Part I","volume":"176","author":"Mancuso","year":"2011","journal-title":"Mil Med"},{"issue":"10","key":"2026051402253304600_bib41","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.7205\/MILMED-D-11-00141","article-title":"Deployment-related testing and treatment for latent tuberculosis infection, Part II","volume":"176","author":"Mancuso","year":"2011","journal-title":"Mil Med"},{"issue":"9","key":"2026051402253304600_bib42","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.5588\/ijtld.10.0542","article-title":"Cost-effectiveness analysis of targeted and sequential screening strategies for latent tuberculosis","volume":"15","author":"Mancuso","year":"2011","journal-title":"Int J Tuberc Lung Dis"},{"issue":"12","key":"2026051402253304600_bib43","first-page":"2","article-title":"Development and implementation of a cohort review for latent tuberculosis infection","volume":"21","author":"Aaron","year":"2014","journal-title":"MSMR"},{"issue":"RR-11","key":"2026051402253304600_bib44","first-page":"1","article-title":"Treatment of tuberculosis","volume":"52","author":"American Thoracic Society, CDC, and Infectious Diseases Society of America","year":"2003","journal-title":"MMWR Recomm Rep"},{"key":"2026051402253304600_bib45","volume-title":"Regional Training and Medical Consultation Centers (RTMCCs)","author":"CDC","year":"2013"},{"key":"2026051402253304600_bib46","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1056\/NEJMe1410977","article-title":"Shortening treatment for tuberculosis \u2013 back to basics","volume":"37","author":"Warner","year":"2014","journal-title":"N Engl J Med"},{"key":"2026051402253304600_bib47","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa1407426","article-title":"Four-month moxifloxacin-based regimens for drug-sensitive tuberculosis","volume":"37","author":"Gillespie","year":"2014","journal-title":"N Engl J Med"},{"issue":"RR-09","key":"2026051402253304600_bib48","first-page":"1","article-title":"Provisional CDC guidelines for the use and safety monitoring of bedaquiline fumarate (Sirturo) for the treatment of multidrug-resistant tuberculosis","volume":"62","author":"CDC","year":"2013","journal-title":"MMWR Recomm Rep"},{"issue":"4","key":"2026051402253304600_bib49","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1473-3099(13)70328-1","article-title":"New antituberculosis drugs, regimens, and adjunct therapies: needs, advances, and future prospects","volume":"14","author":"Zumla","year":"2014","journal-title":"Lancet Infect Dis"},{"issue":"48","key":"2026051402253304600_bib50","first-page":"1650","article-title":"Recommendations for use of an isoniazid-rifapentine regimen with direct observation to treat latent Mycobacterium tuberculosis infection","volume":"60","author":"CDC","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2026051402253304600_bib51","volume-title":"Bureau of Medicine and Surgery (BUMED), BUMED Instruction 6224.8B, Tuberculosis Control Program","author":"Department of the Navy","year":"2013"},{"issue":"4","key":"2026051402253304600_bib52","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/cid\/cit790","article-title":"Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials","volume":"58","author":"Mangtani","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"RR-4","key":"2026051402253304600_bib53","first-page":"1","article-title":"The role of BCG vaccine in the prevention and control of tuberculosis in the United States. A joint statement by the Advisory Council for the Elimination of Tuberculosis and the Advisory Committee on Immunization Practices","volume":"45","author":"CDC","year":"1996","journal-title":"MMWR Recomm Rep"},{"issue":"4","key":"2026051402253304600_bib54","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S2213-2600(14)70033-5","article-title":"Progress in tuberculosis vaccine development and host-directed therapies\u2013a state of the art review","volume":"2","author":"Kaufmann","year":"2014","journal-title":"Lancet Respir Med"},{"issue":"RR-15","key":"2026051402253304600_bib55","first-page":"1","article-title":"Guidelines for the investigation of contacts of persons with infectious tuberculosis. Recommendations from the National Tuberculosis Controllers Association and CDC","volume":"54","author":"National Tuberculosis Controllers Association and Centers for Disease Control and Prevention (CDC)","year":"2005","journal-title":"MMWR Recomm Rep"},{"issue":"RR-9","key":"2026051402253304600_bib56","first-page":"1","article-title":"Prevention and control of tuberculosis in correctional and detention facilities: recommendations from CDC. Endorsed by the Advisory Council for the Elimination of Tuberculosis, the National Commission on Correctional Health Care, and the American Correctional Association","volume":"55","author":"CDC","year":"2006","journal-title":"MMWR Recomm Rep"},{"issue":"RR-5","key":"2026051402253304600_bib57","first-page":"1","article-title":"Progressing toward tuberculosis elimination in low-incidence areas of the United States. Recommendations of the Advisory Council for the Elimination of Tuberculosis","volume":"51","author":"Jereb","year":"2002","journal-title":"MMWR Recomm Rep"},{"key":"2026051402253304600_bib58","volume-title":"CDC Immigration Requirements: Technical Instructions for Tuberculosis Screening and Treatment, Using Cultures and Directly Observed Therapy","author":"CDC","year":"2009"},{"issue":"3","key":"2026051402253304600_bib59","doi-asserted-by":"crossref","first-page":"346","DOI":"10.7205\/MILMED-D-12-00297","article-title":"Tuberculosis among nonimmigrant visitors to US Military installations","volume":"178","author":"Aaron","year":"2013","journal-title":"Mil Med"},{"issue":"10","key":"2026051402253304600_bib60","first-page":"295","article-title":"Monitoring tuberculosis programs\u2014National Tuberculosis Indicator Project, United States, 2002\u20132008","volume":"59","author":"CDC","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2026051402253304600_bib61","volume-title":"Understanding the TB Cohort Review Process: Instruction Guide (2006)","author":"CDC","year":"2012"}],"container-title":["Military Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/milmed\/article-pdf\/180\/3\/276\/68282912\/milmed_180_3_276.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/milmed\/article-pdf\/180\/3\/276\/68282912\/milmed_180_3_276.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T06:25:48Z","timestamp":1778739948000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/milmed\/article\/180\/3\/276\/4160086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,1]]},"references-count":61,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2015,3,1]]},"published-print":{"date-parts":[[2015,3,1]]}},"URL":"https:\/\/doi.org\/10.7205\/milmed-d-14-00433","relation":{},"ISSN":["1930-613X","0026-4075"],"issn-type":[{"value":"1930-613X","type":"electronic"},{"value":"0026-4075","type":"print"}],"subject":[],"published-other":{"date-parts":[[2015,3]]},"published":{"date-parts":[[2015,3,1]]}}}